Adds depth and durability to Mallinckrodt's Specialty Brands segment; further diversifies its portfolio with an innovative high-value, high-margin drug-device system used in hospitals and major medical centers in more than...
Read More
-- Enters into definitive agreement to acquire Therakos, Inc. for $1.325 billion from The Gores Group, LLC ---Transaction expected to be accretive by no less than $0.10 per share to...
Read More